1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics 2022 - Northern Europe

Pathology Analysis & Statistics 2022 - Northern Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Delve Insight

All regions

  • All
    • Europe
      • Northern Europe
1-30 of about 100 reports

Spinal Cord Injury - Pipeline Insight, 2021

  • $ 2000
  • September 2021
  • 80 pages

“Spinal Cord Injury - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Spinal Cord Injury pipeline landscape. It covers the pipeline drug ...

  • World
  • Taiwan
  • Neurological Disorder
  • Industry analysis

Major Depressive Disorder - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 175 pages

‘Major Depressive Disorder (MDD)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Major Depressive Disorder (MDD), historical and forecasted epidemiology in the United ...

  • Spain
  • France
  • Depression
  • Industry analysis

Functional Dyspepsia - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 64 pages

‘Functional Dyspepsia – Epidemiology Forecast—2030’ report delivers an in-depth understanding of Functional Dyspepsia, historical and forecasted epidemiology in the United States, EU5 (Germany, ...

  • Spain
  • Germany
  • Digestive System Disorder
  • Industry analysis

ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2030

  • $ 3750
  • August 2021
  • 80 pages

‘ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology ...

  • United States
  • Spain
  • Breast Cancer
  • Industry analysis

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology forecast- 2030

  • $ 4750
  • August 2021
  • 180 pages

‘Chronic Obstructive Pulmonary Disease (COPD)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Chronic Obstructive Pulmonary Disease (COPD), historical and forecasted ...

  • United States
  • Spain
  • Respiratory Disease
  • Industry analysis
  • Chronic Obstructive Pulmonary Disease Prevalence

Chronic Hepatitis B Virus Infection - Pipeline Insight, 2021

  • $ 2500
  • July 2021
  • 60 pages

“Chronic Hepatitis B Virus Infection - Pipeline Insight, 2021,” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Chronic Hepatitis B Virus Infection pipeline landscape. ...

  • World
  • United Kingdom
  • Hepatitis
  • Industry analysis

Acute Ischemic Stroke - Pipeline Insight, 2021

  • $ 2000
  • May 2021
  • 60 pages

“Acute Ischemic Stroke – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Acute Ischemic Stroke pipeline landscape. It covers the pipeline ...

  • United Kingdom
  • United States
  • Stroke
  • Industry analysis

Glaucoma  - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 156 pages

‘Glaucoma—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Glaucoma , historical and forecasted epidemiology as well as the Glaucoma trends in the United States, EU5 ...

  • Japan
  • Spain
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Sepsis - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 108 pages

‘Sepsis—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Sepsis , historical and forecasted epidemiology as well as the Sepsis trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Blood Disease
  • Industry analysis

Heart Failure - Epidemiology forecast- 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Heart Failure (HF)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the HF, historical and forecasted epidemiology as well as the HF trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Heart Failure
  • Epidemiology
  • Industry analysis

Microscopic Polyangiitis - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Microscopic polyangiitis (MPA) —Epidemiology Forecast–2030’ report delivers an in-depth understanding of the MPA, historical and forecasted epidemiology as well as the MPA epidemiology trends ...

  • Japan
  • Germany
  • Epidemiology
  • Autoimmune Disease
  • Industry analysis
  • Population Size

Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast–2030

  • $ 3750
  • April 2021
  • 90 pages

Overview ‘Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Exocrine Pancreatic Insufficiency ...

  • Japan
  • Spain
  • Digestive System Disorder
  • Industry analysis

Diabetic retinopathy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 90 pages

‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 ...

  • United States
  • Germany
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence

Glioblastoma multiforme (GBM) - Epidemiology Forecast to 2030

  • $ 3750
  • February 2021
  • 171 pages

‘Glioblastoma Multiforme (GBM) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the ...

  • Spain
  • France
  • Brain Cancer
  • Industry analysis

LY3454738- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • February 2021
  • 35 pages

“LY3454738- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Chronic Spontaneous Urticaria in 7 Major Markets. A detailed ...

  • Japan
  • Spain
  • Research And Development
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

Aliqopa - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Aliqopa - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Aliqopa ...

  • Europe
  • Japan
  • Lymphoma
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Acalabrutinib- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“ACALABRUTINIB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

BI 764524 - Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BI 764524 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Blinatumomab- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BLINATUMOMAB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Monoclonal Antibody
  • Industry analysis
  • Health Expenditure

DB-102- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“DB-102- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • World
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

RG 7774 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“RG 7774 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

Loncastuximab tesirine- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“LONCASTUXIMAB TESIRINE- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Therapy
  • Industry analysis
  • Health Expenditure

Treakisym- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“TREAKISYM - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Ublituximab + Umbralisib- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse Large B-Cell Lymphoma in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Therapy
  • Industry analysis
  • Health Expenditure

ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Gaucher disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Research And Development
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Zydelig - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Zydelig - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Zydelig ...

  • Europe
  • Japan
  • Immunotherapy
  • Lymphoma
  • Industry analysis
  • Health Expenditure

PR001 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“PR001 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Gaucher disease in 7 Major Markets. A detailed picture of the PR001 ...

  • Europe
  • Japan
  • Research And Development
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Leustatin - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Leustatin - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Clinical Trial
  • Leukemia
  • Industry analysis
  • Health Expenditure

Lumoxiti- Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Lumoxiti - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • Japan
  • Clinical Trial
  • Leukemia
  • Industry analysis
  • Health Expenditure

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on